Cytokine Levels in Panic Disorder: Evidence for a Dose-Response Relationship

Psychosomatic Medicine

Volumn 79, Issue 2, 2017, Pages 126-132

  Belem Da Silva, Cristiano Tschiedel ^a,b   Costa, Marianna De Abreu ^a,b   Bortoluzzi, Andressa ^c   Pfaffenseller, Bianca ^b   Vedana, Flávia ^a,b   Kapczinski, Flávio ^a,b,c   Manfro, Gisele Gus ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Basic Research and Advanced Investigations in Neurosciences   (United Kingdom)

Author keywords

anxiety disorders; biochemical markers; interleukin 6; neuroinflammation; panic disorder

Indexed keywords

GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PANIC; PROTEIN BLOOD LEVEL; REMISSION; BLOOD; INFLAMMATION; MIDDLE AGED;

ADULT; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PANIC DISORDER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85012067902     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000384     Document Type: Article

References (34)

1. Howren MB Lamkin DM Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-Analysis. Psychosom Med 2009; 71: 171-86.
2. Dowlati Y Herrmann N Swardfager W Liu H Sham L Reim EK Lanctôt KL. A meta-Analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-57.
3. Papakostas GI Shelton RC Kinrys G Henry ME Bakow BR Lipkin SH Pi B Thurmond L Bilello JA. Assessment of a multi-Assay, serum-based biological diagnostic test for major depressive disorder: A Pilot and Replication Study. Mol Psychiatry 2013; 18: 332-9.
4. Oquendo MA McGrath P Weissman MM. Biomarker studies and the future of personalized treatment for depression. Depress Anxiety 2014; 31: 902-5.
5. Isik A Koca SS Ozturk A Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26: 872-8.
6. Kheirandish M Faezi ST Paragomi P Akhlaghi M Gharibdoost F Shahali A Fini ME Akbarian M. Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: An epidemiologic study in Iranian patients. Mod Rheumatol 2015; 25: 405-9.
7. Bae SC Gun SC Mok CC Khandker R Nab HW Koenig AS Vlahos B Pedersen R Singh A. Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. BMC Musculoskelet Disord 2013; 14: 13.
8. Favreau H Bacon SL Labrecque M Lavoie KL. Prospective impact of panic disorder and panic-Anxiety on asthma control, health service use, and quality of life in adult patients with asthma over a 4-year follow-up. Psychosom Med 2014; 76: 147-55.
9. Rohleder N. Stimulation of systemic low-grade inflammation by psychosocial stress. Psychosom Med 2014; 76: 181-9.
10. Hiles SA Baker AL de Malmanche T Attia J. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-Analysis. Psychol Med 2012; 42: 2015-26.
11. Antoni MH Lutgendorf SK Blomberg B Carver CS Lechner S Diaz A Stagl J Arevalo JM Cole SW. Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics. Biol Psychiatry 2012; 71: 366-72.
12. Bhasin MK Dusek JA Chang BH Joseph MG Denninger JW Fricchione GL Benson H Libermann TA. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One 2013; 8: e62817.
13. Hoge EA Brandstetter K Moshier S Pollack MH Wong KK Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009; 26: 447-55.
14. Tükel R Arslan BA Ertekin BA Ertekin E Oflaz S Ergen A Kuruca SE Isbir T. Decreased IFN-γ and IL-12 levels in panic disorder. J Psychosom Res 2012; 73: 63-7.
15. Vogelzangs N Beekman AT de Jonge P Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 2013; 23: e249.
16. Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 2000; 22: 106-15.
17. Shear MK Brown TA Barlow DH Money R Sholomskas DE Woods SW Gorman JM Papp LA. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997; 154: 1571-5.
18. Sheehan DV Lecrubier Y Sheehan KH Amorim P Janavs J Weiller E Hergueta T Baker R Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
20. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-5.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
22. IBGE: DemographicCensus [Internet]. 2000. Rio de Janeiro (Brasil): Instituto Brasileiro de Geografia e Estatística. [updated 2014 may 26; cited 2015 may 17]. Available from: www.ibge.gov.br/censo/. Accessed May 17, 2015.
23. Leng SX McElhaney JE Walston JD Xie D Fedarko NS Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008; 63: 879-84.
24. Hosmer DW Lemeshow S. Applied Logistic Regression. New York: Wiley; 2000.
25. Duivis HE Vogelzangs N Kupper N de Jonge P Penninx BWJH. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 2013; 38: 1573-85.
26. Murphy TM O'Donovan A Mullins N O'Farrelly C McCann A Malone K. Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes. Psychiatr Genet 2015; 25: 71-8.
27. Schmidt FM Lichtblau N Minkwitz J Chittka T Thormann J Kirkby KC Sander C Mergl R Faßhauer M Stumvoll M Holdt LM Teupser D Hegerl U Himmerich H. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res 2014; 55: 29-34.
28. Steptoe A Hamer M Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-Analysis. Brain Behav Immun 2007; 21: 901-12.
29. Engler H Benson S Wegner A Spreitzer I Schedlowski M Elsenbruch S. Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms. Brain Behav Immun 2016; 52: 18-26.
30. Friedman BH. An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biol Psychol 2007; 74: 185-99.
31. Prater KE Hosanagar A Klumpp H Angstadt M Phan KL. Aberrant amygdala-frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder. Depress Anxiety 2013; 30: 234-41.
32. Martinez JM Garakani A Kaufmann H Aaronson CJ Gorman JM. Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients. Psychosom Med 2010; 72: 442-9.
33. Marsland AL Gianaros PJ Prather AA Jennings JR Neumann SA Manuck SB. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 2007; 69: 709-16.
34. Pellissier S Dantzer C Mondillon L Trocme C Gauchez AS Ducros V Mathieu N Toussaint B Fournier A Canini F Bonaz B. Relationship between vagal tone, cortisol, TNF-Alpha, epinephrine and negative affects in Crohn disease and irritable bowel syndrome. PLoS One 2014; 9: e105328.